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Human T cell leukemia virus type 1 (HTLV-1) causes a
fatal hematopoietic malignancy, adult T cell leukemia
(ATL), and a viral oncoprotein Tax is considered to play
the important roles in leukemogenesis through its potent
activation of NF-B. Protein ubiquitination is crucial for
the proper regulation of NF-B pathway. It is also known
that the function of Tax is modified by ubiquitination,
indicating that ubiquitination machineries contribute to
the oncogenic mechanisms of ATL. We report that two
ubiquitin-specific peptidases, USP20 and USP33, deubi-
quitinate TRAF6 and suppress IL-1b-induced NF-B
activation. We find that USP20 deubiquitinates Tax and
inhibits Tax-induced NF-B activation, consistent with
Tax being a substrate of USP20. In HTLV-1-transformed
cells, the transcription of USP20 is reduced compared
with HTLV-1-negative T cells, and ectopic USP20
expression was found to inhibit the proliferation of an
HTLV-1-transformed cell line, MT4. Our findings sug-
gest USP20 is a key negative regulator of NF-B signaling
and can influence HTLV-1-induced leukemogenesis.
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